Delpharm Reims is a finished-dose manufacturer based in France. It appears in 24 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), ARCSA (EC) and MINSA (CR). Its GMP standing is certified by ANSM (FR), ANVISA (Brazil) and EMA.
| Site | FDA FEI |
|---|---|
| 51100 reims, United Arab Emirates | Not on file |
| REIMS, France | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 10 | None |
| ARCSA (EC) | 6 | None |
| MINSA (CR) | 3 | None |
| NAFDAC (NG) | 1 | None |
| NCELS (KZ) | 1 | None |
| NPRA (MY) | 1 | None |
| ANSM (FR) | None | 8 |
| ANVISA (Brazil) | None | 2 |
| EMA | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $94.0M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Delpharm Reims comes back tiered against every other supplier able to file there.
Start for free